Sign Up to like & get
recommendations!
1
Published in 2022 at "Bioinorganic Chemistry and Applications"
DOI: 10.1155/2022/5176300
Abstract: Di-n-butyl-di-(4-chlorobenzohydroxamato) tin(IV) (DBDCT), a new patent agent, exhibited strong antitumor activity. In some cases, its activity was close to or even higher than cisplatin, a first-line clinical metallic agent. Similar to platinum compounds, it also…
read more here.
Keywords:
apoptosis;
induced hepatotoxicity;
targets dbdct;
dbdct induced ... See more keywords